Last Minutes! USA's Moderna's coronavirus vaccine has 100% effect in serious cases

Last minutes! US biotech company Moderna made 3 at the weekend. he explained that the success rate in Phase vaccine trials was 94.1 percent. In serious cases, this rate was 100 percent.

US biotech company Moderna has announced that the coronavirus vaccine they have developed has not encountered any complications, with a success rate of 94.1 percent, and will apply for an emergency use permit.

30 THOUSAND PEOPLE WERE VACCINATED

In vaccine studies with more than 30 thousand people, Moderna said that 185 of 196 coronavirus patients received the vaccine, while 11 received a placebo. Thirty people among these patients were reported to have serious cases, while all of those thirty reported that the vaccine was effective.

"WE HOPE TO PLAY AN IMPORTANT ROLE IN ERADICATING THE EPIDEMIC"

A doctor who heads Moderna's vaccine team "We believe we have a highly effective vaccine," Tal Zaks said in a statement. Now we have the data to prove it. We hope to play an important role in eradicating this epidemic," he said.

"THERE IS NO STATISTICALLY SIGNIFICANT DIFFERENCE"

Moderna reported on November 16 that the vaccine they were working on was 94.5 percent. In the last statement, the rate fell to 94.1 percent. Tal Zaks noted that this ratio is not a statistically significant difference.

IT'S THE SECOND VACCINE TO APPLY FOR AN EMERGENCY USE PERMIT

Moderna is the second vaccine to apply for an emergency use permit after the Pfizer-Biontech vaccine, which applied for an emergency use permit last week. The effectiveness of the Pfizer-Biontech vaccine was 95 percent.